STUDY ON THE MECHANISM OF HIV/SIV-INDUCED SYNCYTIUM FORMATION USING TRANSFORMANTS EXPRESSING CHIMERA CD4 AMONG SEVERAL SPECIES OF MACAQUES.
STUDY ON THE MECHANISM OF HIV/SIV-INDUCED SYNCYTIUM FORMATION USING TRANSFORMANTS EXPRESSING CHIMERA CD4 AMONG SEVERAL SPECIES OF MACAQUES.
批准号:
08456164
负责人:
TATSUMI Masashi
金额:
$4.29万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997
中文摘要
到目前为止,人们从分子水平对SIV和HIV-1进行了广泛的研究,以阐明决定其宿主范围的机制。相比之下,对猕猴宿主细胞受体(S)的研究到目前为止还很有限。我们已经报道了几个猕猴CD4在人类细胞系上表达时可以作为HIV-1的受体,而不是在猕猴细胞上表达,并且这些猕猴CD4基因在整个编码区有很高的同源性,尽管在HIV-1诱导的合胞体形成方面在这些猕猴CD4表达转化子中发现了关键的差异。关于除V1以外的其他结构域在合体形成中的作用仍存在争议,在V1中定义了与gp120的结合部位。由于猕猴…在编码区具有很高的同源性,但在合体形成方面的表型不同,可能为进一步解决这一问题提供了一个合适的实验系统,我们试图表达CD4更多的S嵌合的CD_4来源于几个猕猴的CD_4,它们形成合胞体的能力不同,以阐明结构域结构与HIV-1诱导的合胞体形成敏感性之间的关系。我们选择日本猴(JpT4)的CD4cDNAs作为合胞体阳性表型,食蟹猴(CyT4)的CD4cDNAs作为合胞体阴性表型。我们利用这两个猕猴CD4之间保守的两个酶切位点,构建了一组哺乳动物表达载体,其中含有多个嵌合的CD4cDNAs,在G418的选择压力下,转染了人细胞系HeLa,建立了几个稳定表达嵌合CD4分子的转化子。然后将这些转化子与具有感染性的分子克隆HIV-1NL432接触,以研究每个嵌合的CD4是否能够支持合胞体的形成。合胞体仅在由阳性表型衍生的V2和V3结构域的转化子表达的情况下发生。比较JpT4和CyT4的氨基酸序列,在第144位氨基酸上只有一个差异:Leu(CyT4)和Ile(JpT4)。接下来,我们通过定点突变的方法构建了在第144位含有Ile的CyT4突变体,并建立了表达CyT4突变体的转化子,发现该突变体在暴露于HIV-1后形成合胞体。综上所述,这些发现表明,除了V1结构域作为gp120的直接结合部位外,另一个涉及144个氨基酸的V2结构域可能在合体形成中发挥重要作用,作为gp120的第二结合部位,或有效地使gp120与含有疏水融合结构域的gp41非共价结合。这些实验系统可能提供一种分析工具,以深入了解HIV-1进入HIV-1过程中CD4和HIV-1之间的相互作用。较少
英文摘要
So far SIV and HIV-1 have been extensively studied from the molecular aspects to elucidate the mechanisms determining its host range. In contrast, studies on the cellular receptor(s) of hosts, macaque monkeys are limited until now. We have already reported that several macaque monkey CD4s could serve as a receptor for HIV-1 when expressed on a human cell line but not a monkey cells, and that there is high homology in the entire coding region among these macaque monkey CD4 genes although critical differences were detected in syncytium formation induced by HIV-1 among these macaque CD4 expressing transformants. There are still controversies on the role in syncytium formation of other domains of CD4 molecule than V1, in which the binding site to gp120 is defined. Since macaque monkey CD4s showing high homology in the coding region but different phenotypes in term of syncytium formation might provide a suitable experimental system to address this issue further, we make an attempt to expres … More s chimeric CD4 derived from several macaque monkey CD4s, which differ in the ability of syncytium formation to elucidate the relationship between domain strucrures and susceptibilities to syncytium formation induced by HIV-1. We chose monkey CD4 cDNAs from japanese monkey (JpT4) as a syncytium positive phenotype and from cynomolgus monkey (CyT4) as a syncytium negative phenotype. We construct an array of mammalian expression vectors which contain several chimeric CD4 cDNAs among these macaque CD4s by using the two restriction sites conserved between these two macaque CD4s, transfected a human cell line HeLa under the selection pressure of G418 and established several stable transformants expressing chimeric CD4 molecule. These transformants were then exposured with an infectious molecular clone HIV-1NL432 to study whether or not each chimeric CD4 can support the syncytium formation. Syncytia occurred only in the cases of transformants expression of V2 and V3 domains derived from the positive phenotype. On the comparison of amino acid sequence in such regions between JpT4 and CyT4, there was only one difference at the 144th amino acid ; Leu (CyT4) and Ile (JpT4). Next we construct the CyT4 Mutant which contained Ile at 144th position by site-directed mutagenesis and established a transformant expressing CyT4 mutant, which was revealed to form syncytia after exposure to HIV-1. Taken together, these findings indicated that aside from the V1 domain as the direct binding site for gp120, the other V2 domain involving 144th amino acid might play an important role in the syncytium formation as the second binding site for gp120 or for the effective shedding of gp120 from noncovalent association with gp41, which contains the hydrophobic fusion domain. These experimental system might provide an analytical tool to shed some insight into the interaction between CD4 and HIV-1 on the HIV-1 entry. Less
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Yabe,M.,Matsuura,Y.and Tatsumi,M.: "Molecular cloning and expression of cynomolgus monkey IL-2 cDNA by the baculovirus system." Int.Arches.Immunol.Allergy. (in press). (1997)
Yabe,M.、Matsuura,Y. 和 Tatsumi,M.:“通过杆状病毒系统进行食蟹猴 IL-2 cDNA 的分子克隆和表达。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Li, T-C,Yamakawa, Y., Suzuki, k., Tatsumi, M., Razak, M.A., Uchida, T., Takeda, N., and Miyamura, T.: "Expression and self-assembly of empty virus-like particles of hepatitis E virus." J.Virol.71. 7207-7213 (1997)
Li, T-C、Yamakawa, Y.、Suzuki, k.、Tatsumi, M.、Razak, M.A.、Uchida, T.、Takeda, N. 和 Miyamura, T.:“空病毒样的表达和自组装
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Li,T-Cet al:"Expression and self-assembly of empty virus-like particles of hepatitis E virus." J.Virol.71. 7207-7213 (1997)
Li,T-Cet al:“戊型肝炎病毒空病毒样颗粒的表达和自组装。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takakura, H., Mori, Y., and Tatsumi, M.: "Molecular cloning and expression of caprine IL-6 cDNA in insect cells." Int.Archiev Allergy Immunol.113. 409-416 (1997)
Takakura, H.、Mori, Y. 和 Tatsumi, M.:“山羊 IL-6 cDNA 在昆虫细胞中的分子克隆和表达。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Totsuka, K., Takakura, H., Hashimoto, O.and Tatsumi, M.: "Molecular cloning and Expression of cynomolgus monkey Interleukin-1β." Int.Archiev Allergy Immunol.115(in press).
Totsuka, K.、Takakura, H.、Hashimoto, O. 和 Tatsumi, M.:“食蟹猴 Interleukin-1β 的分子克隆和表达。Int.Archiev Allergy Immunol.115(出版中)。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 13 条
MOLECULAR CLONING AND EXPRESSION OF MACAQUE MONKEY CD4 GENES ; FOR ESTABLISHMENT OF AIDS ANIMAL MODELS.
-
批准号:05454120
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.22万
-
财政年份:1993
-
负责人:TATSUMI Masashi
-
依托单位:
CD4 and CD8 Molecules of Non-human Primates; Molecular Cloning and Their Roles in SIV Infection
-
批准号:03454109
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.16万
-
财政年份:1991
-
负责人:TATSUMI Masashi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
梅毒螺旋体外膜蛋白Tp92经由宿主膜蛋白互作调控MYC诱导CD4⁺ T细胞衰老的分子机制
-
批准号:2026JJ60545
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘兆平
-
依托单位:
CD153 通过 NF-κB 通路调控 Mtb 特异性 CD4⁺T 细胞功能及临床转化研究
-
批准号:2026JJ82221
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘敏
-
依托单位:
平常拟杆菌通过JAK-STAT信号通路调控初始CD4⁺T细胞CD25表达在2型糖尿病中的机制研究
-
批准号:2026JJ82045
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:石婷
-
依托单位:
共轭亚油酸通过HNF4γ驱动CD4⁺CD8αα⁺ IELs代谢重编程抵抗沙门菌感染的分子机制
-
批准号:32503056
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:邓磊
-
依托单位:
PCV2感染促进初始CD4⁺T细胞向Tregs分化的分子机制研究
-
批准号:32573382
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2025
-
负责人:黄勇
-
依托单位:
自身免疫性溶血性贫血中STAT1通过UHRF1/GATA2/P300轴促进CD4细胞Th17分化机制研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:李振江
-
依托单位:
CD4在甲状旁腺细胞的异位表达在甲状旁腺功能亢进症中的作用及机制研究
-
批准号:82470822
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2024
-
负责人:耿冲
-
依托单位:
NEAT1-miR-361-5p-SLC25A5轴影响滋养细胞功能及CD4细胞分化参与子痫前期发病及子代发育的研究
-
批准号:2024Y9012
-
项目类别:省市级项目
-
资助金额:50.0万元
-
批准年份:2024
-
负责人:李蕊
-
依托单位:
自身免疫性溶血性贫血中STAT1通过UHRF1/GATA2/P300轴促进CD4细胞Th17分化机制研究
-
批准号:82460028
-
项目类别:地区科学基金项目
-
资助金额:32.00万元
-
批准年份:2024
-
负责人:李振江
-
依托单位:
IL-16/CD4轴促进Th1细胞激活参与高血压的作用及机制研究
-
批准号:82370426
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:王继光
-
依托单位: